• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死后以高流速冠状动脉内递送间充质干细胞可改善猪的冠状动脉远端血流并降低死亡率。

Intracoronary delivery of mesenchymal stem cells at high flow rates after myocardial infarction improves distal coronary blood flow and decreases mortality in pigs.

作者信息

Llano Raul, Epstein Samuel, Zhou Rong, Zhang Hualei, Hamamdzic Damir, Keane Martin G, Freyman Toby, Wilensky Robert L

机构信息

Cardiovascular Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Catheter Cardiovasc Interv. 2009 Feb 1;73(2):251-7. doi: 10.1002/ccd.21781.

DOI:10.1002/ccd.21781
PMID:19085935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2835520/
Abstract

OBJECTIVES

Evaluate the effects of pressure and duration of intracoronary (IC) infusion of mesenchymal stem cells (MSCs) on delivery efficiency and safety after myocardial infarction (MI).

BACKGROUND

Standard IC delivery of MSCs can lead to intravascular plugging and reduced coronary blood flow. The optimal delivery pressure and duration is unknown.

METHODS

Immediately after MI pigs were randomized to 1 of 3 delivery protocols of 5 x 10(7) iron-fluorescent microspheres labeled MSCs, control received 2 ml infusions at 1 ml/min (five times), very high flow rate (VHFR) a single 10 ml infusion at 60 ml/min and the high flow rate (HFR) group a single 10 ml infusion at 20 ml/min. TIMI grade flow was assessed throughout the procedure and at sacrifice (day 14). MSCs distribution was analyzed in isolated hearts by 4.7T MRI. Delivery efficiency was quantified via fluorescent microsphere recovery using a magnetic separation technique and by light microscopy.

RESULTS

TIMI grade flow did not change following MI (all groups TIMI 3). However, following MSCs delivery only 18% (2/11) of control animals had TIMI 3 blood flow vs. 56% (5/9) in VHFR and 67% (4/6) in HFR (P = 0.03). As a consequence, 63% of control animals died within 24 hr, 33% in VHFR and none in HFR (P = 0.02). MSCs delivery in the infarct tissue did not differ between the groups (P = 0.06).

CONCLUSIONS

A single MSCs infusion at 20 ml/min resulted in improved coronary blood flow and decreased mortality, without sacrificing delivery efficiency.

摘要

目的

评估心肌梗死(MI)后冠状动脉内(IC)输注间充质干细胞(MSCs)的压力和持续时间对递送效率及安全性的影响。

背景

MSCs的标准IC递送可导致血管内堵塞并减少冠状动脉血流。最佳递送压力和持续时间尚不清楚。

方法

MI后立即将猪随机分为3种递送方案之一,即5×10⁷个铁荧光微球标记的MSCs,对照组以1 ml/min的速度输注2 ml(共5次),极高流速(VHFR)组以60 ml/min的速度单次输注10 ml,高流速(HFR)组以20 ml/min的速度单次输注10 ml。在整个操作过程中及处死时(第14天)评估心肌梗死溶栓试验(TIMI)血流分级。通过4.7T磁共振成像(MRI)分析分离心脏中的MSCs分布。使用磁分离技术并通过光学显微镜,通过荧光微球回收对递送效率进行定量。

结果

MI后TIMI血流分级未改变(所有组TIMI 3级)。然而,在输注MSCs后,对照组动物中只有18%(2/11)具有TIMI 3级血流,而VHFR组为56%(5/9),HFR组为67%(4/6)(P = 0.03)。因此,63%的对照组动物在24小时内死亡,VHFR组为33%,HFR组无死亡(P = 0.02)。各组间梗死组织中的MSCs递送无差异(P = 0.06)。

结论

以20 ml/min的速度单次输注MSCs可改善冠状动脉血流并降低死亡率,且不影响递送效率。

相似文献

1
Intracoronary delivery of mesenchymal stem cells at high flow rates after myocardial infarction improves distal coronary blood flow and decreases mortality in pigs.心肌梗死后以高流速冠状动脉内递送间充质干细胞可改善猪的冠状动脉远端血流并降低死亡率。
Catheter Cardiovasc Interv. 2009 Feb 1;73(2):251-7. doi: 10.1002/ccd.21781.
2
Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution.冠状动脉内和逆行冠状静脉心肌内注射脂肪来源干细胞可导致猪梗塞后的短暂心肌滞留,主要向肺部重新分布。
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E17-25. doi: 10.1002/ccd.24659. Epub 2013 Oct 7.
3
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.一项评估心肌梗死后三种间充质干细胞递送方法的定量随机研究。
Eur Heart J. 2006 May;27(9):1114-22. doi: 10.1093/eurheartj/ehi818. Epub 2006 Mar 1.
4
Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI.心肌梗死后经冠状动脉内注射骨髓祖细胞的长期 MRI 跟踪研究。
Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H125-33. doi: 10.1152/ajpheart.01260.2008. Epub 2010 Apr 23.
5
Early improvement in cardiac tissue perfusion due to mesenchymal stem cells.间充质干细胞导致心脏组织灌注的早期改善。
Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2002-11. doi: 10.1152/ajpheart.00762.2007. Epub 2008 Feb 29.
6
Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction.在猪心肌梗死模型中,静脉输注间充质干细胞可增强局部灌注并改善心室功能。
Basic Res Cardiol. 2008 Nov;103(6):525-36. doi: 10.1007/s00395-008-0741-0. Epub 2008 Aug 14.
7
Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model.磁性标记间充质干细胞移植改善猪心肌梗死模型的心功能
Chin Med J (Engl). 2008 Mar 20;121(6):544-50.
8
Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.自体间充质干细胞移植后梗死边缘区的功能和生物能量调节
Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1772-80. doi: 10.1152/ajpheart.00242.2007. Epub 2007 Jun 15.
9
Regenerative capacity of intravenous autologous, allogeneic and human mesenchymal stem cells in the infarcted pig myocardium-complicated by myocardial tumor formation.梗死猪心肌中静脉注射自体、异体和人间充质干细胞的再生能力——并发心肌肿瘤形成
Scand Cardiovasc J. 2009 Feb;43(1):39-45. doi: 10.1080/14017430802100280.
10
Intracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction.在急性心肌梗死的转化模型中,冠状动脉内注射同种异体脂肪组织来源的间充质干细胞可改善心肌灌注,但不能改善左心室功能。
J Am Heart Assoc. 2017 May 3;6(5):e005771. doi: 10.1161/JAHA.117.005771.

引用本文的文献

1
PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.过氧化物酶体增殖物激活受体β/δ 预激活增强间充质基质细胞在心肌缺血再灌注损伤中的抗凋亡和治疗作用。
Stem Cell Res Ther. 2022 Apr 23;13(1):167. doi: 10.1186/s13287-022-02840-0.
2
Left Ventricular Unloading Using an Impella CP Improves Coronary Flow and Infarct Zone Perfusion in Ischemic Heart Failure.经皮左心室辅助装置(Impella CP)辅助左心室降低负荷可改善缺血性心力衰竭患者的冠脉血流和梗死区灌注。
J Am Heart Assoc. 2018 Mar 7;7(6):e006462. doi: 10.1161/JAHA.117.006462.
3
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol.评估间充质基质细胞治疗急性心肌梗死临床前模型的安全性和有效性:系统评价方案。
Syst Rev. 2017 Nov 7;6(1):226. doi: 10.1186/s13643-017-0601-9.
4
Intracoronary Delivery of Human Mesenchymal/Stromal Stem Cells: Insights from Coronary Microcirculation Invasive Assessment in a Swine Model.人骨髓间充质/基质干细胞的冠状动脉内递送:来自猪模型冠状动脉微循环侵入性评估的见解
PLoS One. 2015 Oct 19;10(10):e0139870. doi: 10.1371/journal.pone.0139870. eCollection 2015.
5
Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution.冠状动脉内和逆行冠状静脉心肌内注射脂肪来源干细胞可导致猪梗塞后的短暂心肌滞留,主要向肺部重新分布。
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E17-25. doi: 10.1002/ccd.24659. Epub 2013 Oct 7.
6
Cell therapy for cardiovascular disease: a comparison of methods of delivery.细胞治疗心血管疾病:递送方法的比较。
J Cardiovasc Transl Res. 2011 Apr;4(2):177-81. doi: 10.1007/s12265-010-9253-z. Epub 2010 Dec 23.
7
Delayed recovery of myocardial blood flow after intracoronary stem cell administration.冠状动脉内干细胞给药后心肌血流的延迟恢复。
Stem Cell Rev Rep. 2011 Sep;7(3):616-23. doi: 10.1007/s12015-010-9213-7.
8
Intracoronary delivery of bone-marrow-derived stem cells.冠状动脉内递送骨髓源干细胞。
Stem Cell Res Ther. 2010 Sep 23;1(4):29. doi: 10.1186/scrt29.

本文引用的文献

1
Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart.磁共振成像高估了移植至心脏的铁氧化物标记干细胞的存活率。
Circulation. 2008 Mar 25;117(12):1555-62. doi: 10.1161/CIRCULATIONAHA.107.732073. Epub 2008 Mar 10.
2
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.急性心肌梗死患者直接经皮冠状动脉介入治疗后冠状动脉内输注自体单核骨髓细胞:多中心HEBE试验的初步研究
Catheter Cardiovasc Interv. 2008 Feb 15;71(3):273-81. doi: 10.1002/ccd.21337.
3
A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction.急性心肌梗死后经心内膜注射异体间充质干细胞的安慰剂对照、剂量范围、安全性研究。
Eur Heart J. 2008 Jan;29(2):251-9. doi: 10.1093/eurheartj/ehm559. Epub 2007 Dec 11.
4
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.急性心肌梗死犬模型中同种异体间充质细胞冠状动脉内给药与经心内膜给药的比较。
J Mol Cell Cardiol. 2008 Mar;44(3):486-95. doi: 10.1016/j.yjmcc.2007.09.012. Epub 2007 Oct 4.
5
Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size.静脉注射的间充质干细胞在冠状动脉闭塞后归巢至存活心肌,可保留收缩功能而不改变梗死面积。
Int J Cardiol. 2007 Oct 31;122(1):17-28. doi: 10.1016/j.ijcard.2006.11.022. Epub 2006 Dec 21.
6
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.急性心肌梗死中的冠状动脉内骨髓源性祖细胞
N Engl J Med. 2006 Sep 21;355(12):1210-21. doi: 10.1056/NEJMoa060186.
7
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.一项评估心肌梗死后三种间充质干细胞递送方法的定量随机研究。
Eur Heart J. 2006 May;27(9):1114-22. doi: 10.1093/eurheartj/ehi818. Epub 2006 Mar 1.
8
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.自体骨髓源性干细胞移植治疗ST段抬高型心肌梗死患者:双盲随机对照试验
Lancet. 2006 Jan 14;367(9505):113-21. doi: 10.1016/S0140-6736(05)67861-0.
9
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction.心肌梗死后经心内注射同种异体间充质干细胞进行心脏修复。
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11474-9. doi: 10.1073/pnas.0504388102. Epub 2005 Aug 1.
10
Unchain my heart: the scientific foundations of cardiac repair.解放我的心脏:心脏修复的科学基础。
J Clin Invest. 2005 Mar;115(3):572-83. doi: 10.1172/JCI24283.